Leaderboards/Polyomavirus and related diseases

Polyomavirus and related diseases

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Joo-Yoon Chung
Inha University
2
Zunaid Ahmed
Stellenbosch University
3
Kaili Long
Nanjing Normal University
4
Xinzhe Tang
Center for Excellence in Molecular Cell Science
5
Antonio Marzio
New York University
6
Chu Xie
Sun Yat-sen University
7
Natalia Dominik
National Hospital for Neurology and Neurosurgery
8
Luisa Galati
European Institute of Oncology
9
Fuyi Liao
Washington University in St. Louis
10
Cecilia Smith Simonsen
Drammen Hospital

Papers

1
Publication in Viruses (2024) [39 citations, W4392594998]
Viruses|2024
39 cit.
2
The influence of menopause on multiple sclerosis
European Journal of Neurology|2024
12 cit.
3
Navigating Epstein–Barr virus autoimmunity: role of NK cells and T cells in multiple sclerosis
Signal Transduction and Targeted Therapy|2024
9 cit.
4
Reduced childbirth rates in multiple sclerosis from the prodromal phase: Evidence from a population-based cohort study
Multiple Sclerosis Journal|2025
5 cit.
5
Publication in Journal of Medical Virology (2025) [5 citations, W4408244811]
Journal of Medical Virology|2025
5 cit.
6
Human herpesvirus 6B glycoprotein B postfusion structure, vulnerability mapping, and receptor recognition
PLoS Pathogens|2025
3 cit.
7
Lower threshold for hormone therapy in women with multiple sclerosis
Tidsskrift for Den norske legeforening|2025
2 cit.
8
Publication in Zeitschrift für Gastroenterologie (2025) [W4410333677]
Zeitschrift für Gastroenterologie|2025
0 cit.
9
Publication in Zeitschrift für Gastroenterologie (2025) [W4410334061]
Zeitschrift für Gastroenterologie|2025
0 cit.
10
Publication in Journal of Clinical Investigation (2025) [W4415166562]
Journal of Clinical Investigation|2025
0 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Kathleen J. Ramos
University of Washington
2
Alberto Ciccia
Cancer Genetics (United States)
3
Andrew S. Brohl
Moffitt Cancer Center
4
Henri Marc Bourbon
Centre National de la Recherche Scientifique
5
Mohammad Moniruzzaman
University of Miami
6
Anh D. Ha
Virginia Tech
7
Melissa S. Maginnis
University of Maine
8
Martina Absinta
Humanitas University
9
Liesbet M. Peeters
Hasselt University
10
Martin Merschhemke
Novartis (Switzerland)

Papers

1
Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial
The Lancet|2022
134 cit.
2
SMARCAL1 is a dual regulator of innate immune signaling and PD-L1 expression that promotes tumor immune evasion
Cell|2024
93 cit.
3
B cell depletion therapy does not resolve chronic active multiple sclerosis lesions
EBioMedicine|2023
83 cit.
4
Updated Results of the COVID-19 in MS Global Data Sharing Initiative
Neurology Neuroimmunology & Neuroinflammation|2022
53 cit.
5
Virologs, viral mimicry, and virocell metabolism: the expanding scale of cellular functions encoded in the complex genomes of giant viruses
FEMS Microbiology Reviews|2023
49 cit.
6
Use of elexacaftor/tezacaftor/ivacaftor among cystic fibrosis lung transplant recipients
Journal of Cystic Fibrosis|2022
47 cit.
7
Assessing the biogeography of marine giant viruses in four oceanic transects
ISME Communications|2023
39 cit.
8
Endogenous giant viruses contribute to intraspecies genomic variability in the model green alga <i>Chlamydomonas reinhardtii</i>
Virus Evolution|2022
32 cit.
9
A glia-enriched stem cell 3D model of the human brain mimics the glial-immune neurodegenerative phenotypes of multiple sclerosis
Cell Reports Medicine|2024
31 cit.
10
The impact of elexacaftor/tezacaftor/ivacaftor on fat-soluble vitamin levels in people with cystic fibrosis
Journal of Cystic Fibrosis|2023
29 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Paul Nghiem
Fred Hutch Cancer Center
2
Patrick S. Moore
UPMC Hillman Cancer Center
3
E. Donnall Thomas
Centre d'Investigation Clinique Antilles Guyane
4
Hans H. Hirsch
Department of Biomedicine Basel
5
Bruce Stillman
Cold Spring Harbor Laboratory
6
Rainer Storb
Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa
7
Kamel Khalili
Temple University
8
Michael Boeckh
Fred Hutch Cancer Center
9
Walter J. Atwood
Brown University
10
Igor J. Koralnik
Northwestern University

Papers

1
Identification of Herpesvirus-Like DNA Sequences in AIDS-Sssociated Kaposi's Sarcoma
Science|1994
5.7k cit.
2
CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,S
Transplantation|1974
3.7k cit.
3
Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma
Science|2008
3.2k cit.
4
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
Biology of Blood and Marrow Transplantation|2009
1.8k cit.
5
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
Nature|1994
1.7k cit.
6
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)
Proceedings of the National Academy of Sciences|1996
1.5k cit.
7
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
New England Journal of Medicine|1986
1.5k cit.
8
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects
Blood|2001
1.4k cit.
9
ATP-dependent recognition of eukaryotic origins of DNA replication by a multiprotein complex
Nature|1992
1.3k cit.
10
PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma
New England Journal of Medicine|2016
1.2k cit.

Reagents for Polyomavirus and related diseases

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling Technology

SEK1/MKK4 Antibody

Cited in 7 papers
#9152$317
View Evidence →
Cell Signaling TechnologyEvidence 68

Phospho-TBK1/NAK (Ser172) (D52C2) Rabbit Monoclonal Antibody (PE Conjugate)

Cited in 6 papers
#13498$191,493
View Evidence →
Cell Signaling TechnologyEvidence 66

HSP90 (C45G5) Rabbit Monoclonal Antibody (SignalFlex™ Alexa Fluor® 555 Conjugate)

Cited in 5 papers
#90425$458
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 65

CYP17A1 (E6A7G) Rabbit Monoclonal Antibody (BSA and Azide Free)

Cited in 23 papers
#49449$865
View Evidence →
Cell Signaling Technology

MEIS1/2 Antibody

Cited in 11 papers
#12744$317
View Evidence →
Cell Signaling Technology

PACT (D9N6J) Rabbit Monoclonal Antibody

Cited in 7 papers
#13490$161,351
View Evidence →